Douglas Matthew Brown - 30 Dec 2021 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Chief Strategy Officer
Signature
/s/ Doug M Brown
Issuer symbol
NEO
Transactions as of
30 Dec 2021
Net transactions value
$0
Form type
4
Filing time
30 Dec 2021, 17:02:27 UTC
Previous filing
26 Nov 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +30,572 +263% $0.000000 42,216 30 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 45,017 30 Dec 2021 Common Stock 45,017 $28.33 Direct F2
holding NEO Stock Option (Right to Buy) 26,378 30 Dec 2021 Common Stock 26,378 $53.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 30, 2021, Mr. Brown was granted 30,572 restricted stock awards. These awards vest ratably over three years with the first tranche vesting on December 31, 2022.
F2 On March 2, 2020, Mr. Brown was granted 45,017 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F3 On March 2, 2021, Mr. Brown was granted 26,378 stock options. These options vest ratably over the first four anniversary dates of the grant date.